HYDERABAD: Vaccine maker Bharat Biotech on Monday said it has successfully developed India’s first vaccine candidate for Covid-19 in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). Called Covaxin, the indigenous, inactivated vaccine has also got approval from the Indian drugs regulator, Drug Controller General of India (DCGI), for conducting phase I and II human clinical trials that will begin across the country in July 2020, Bharat Biotech said. The SARS-CoV-2 virus strain was isolated from an asymptomatic Covid-19 patient at NIV, Pune, and transferred to Bharat Biotech, which grew and replicated the virus and developed the vaccine candidate at its BSL-3 (Bio Safety Level-3) high containment facility manufacturing facility at Genome Valley
You are here
Home > Posts tagged "drug controller"